Who owns Nephros Inc?
- Ticker: NEPH
- CUSIP Number: 640671400
Tip: Access positions for across all investors
Analyze quarterly positions in Nephros with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Nephros stock
Who bought or sold Nephros Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wexford Capital | 3.6M | $17M | 0% | Sep 2025 |
|
| Vanguard Group | 281k | $1.3M | -13% | Sep 2025 |
|
| Bard Associates | 127k | $601k | -3% | Sep 2025 |
|
| Renaissance Technologies | 83k | $390k | 657% | Sep 2025 |
|
| Geode Capital Management | 76k | $359k | -19% | Sep 2025 |
|
| HighTower Advisors | 56k | $264k | 0% | Sep 2025 |
|
| William Blair $ Company | 36k | $172k | 0% | Sep 2025 |
|
| Essex Investment Management | 25k | $117k | 0% | Sep 2025 |
|
| Goldman Sachs Group | 19k | $88k | 100% | Sep 2025 |
|
| Citadel Advisors | 17k | $78k | 39% | Sep 2025 |
|
| State Street Corporation | 16k | $74k | 0% | Sep 2025 |
|
| XTX Topco | 15k | $69k | 100% | Sep 2025 |
|
| Mesirow Financial Investment Management International Equity | 14k | $65k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 14k | $64k | 100% | Sep 2025 |
|
| Elkhorn Partners Limited Partnership | 13k | $59k | -14% | Sep 2025 |
|
| Susquehanna International | 10k | $49k | -65% | Sep 2025 |
|
| Morgan Stanley | 1.9k | $7.8k | 100% | Jun 2025 |
|
| Advisor Group Holdings | 175.00 | $826.997500 | 0% | Sep 2025 |
|
| Barclays | 106.00 | $500.998400 | 100% | Sep 2025 |
|
| UBS Group | 66.00 | $312.001800 | -97% | Sep 2025 |
|
| Jones Financial Companies, L.L | 31.00 | $137.999600 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 2.00 | $0 | 0% | Sep 2025 |
|
Who sold out of Nephros?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tower Research Capital | Jun 2025 | 1.1k | $4.5k |
| Jpmorgan Chase & Co | Mar 2025 | 13.00 | $21.999900 |